{"meta":{"query_hash":"38959594d2ac","filters":{"venue":"Chinese Medical Journal BioMed"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/38959594d2ac","api":"https://metacan.xera.ac/api/v1/cohort?venue=Chinese+Medical+Journal+BioMed"},"results":[{"id":"W7133962746","doi":"10.65457/cmjbm-2025-0001","title":"Advances in macrophage metabolic reprogramming in hematological malignancies","year":2025,"lang":"en","type":"article","venue":"Chinese Medical Journal BioMed","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Macrophage; Reprogramming; Immunotherapy; Innate immune system; Immune system; Metabolic pathway; Cancer immunotherapy","score_opus":0.005307685022425938,"score_gpt":0.2911832013988116,"score_spread":0.28587551637638564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133962746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053093834,0.98821473,0.0019245063,0.0014380802,0.0005075328,0.000013010656,0.000057864057,0.000029025954,0.0025058761],"genre_scores_gemma":[0.033574082,0.96151406,0.0020371766,0.001016801,0.00087463757,0.000024306612,0.00013208945,0.0000071663117,0.00081973703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974316,0.000062616455,0.000037449732,0.000049534494,0.00006664845,0.000040669795],"domain_scores_gemma":[0.9997938,0.000079420184,0.000029315604,0.000010128989,0.000064857595,0.000022520675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008556523,0.00042625944,0.0006082394,0.0011269415,0.0002843192,0.00073869457,0.0003361109,0.00065309525,0.0011765093],"category_scores_gemma":[0.0005445558,0.00016063984,0.00061281567,0.0008277554,0.0003658224,0.0011447535,0.0006089427,0.0011050181,0.00026597202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042580874,0.00014485368,0.00424669,0.018830776,0.00023189532,0.0013776063,0.0006417826,0.0013033594,0.0535226,0.017983684,0.019443445,0.8818476],"study_design_scores_gemma":[0.00005354429,0.00053468894,0.007859565,0.002496562,0.00063464616,0.0050541786,0.00061934453,0.0011434726,0.03449074,0.0115613155,0.9354612,0.000090796224],"about_ca_topic_score_codex":0.0006108598,"about_ca_topic_score_gemma":0.000865064,"teacher_disagreement_score":0.0011765093,"about_ca_system_score_codex":0.00053200335,"about_ca_system_score_gemma":0.0009996921,"threshold_uncertainty_score":0.0045251846},"labels":[],"label_agreement":null}]}